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LETTER TO THE EDITOR Open Access
Paradigm shift in head and neck oncology
patient management
Chiquit van Linden van den Heuvell1*, Florence van Zuuren2, Mary Wells3,4, Geert van der Laan1
and Harry Reintsema1
Abstract
Objective: This article describes a paradigm shift in what is considered to be good care for patients living with and
after (head and neck) cancer. HNO patients often experience severe and difficult physical and psychosocial problems
due to the nature and location of the disease. Many disciplines are involved in their treatment, so their voice is only one
amongst many others in the decision making process. For this patient group it seems complicated to put the
concept of Shared Decision Making into practice. As a step in this direction, patient reported outcomes which
ask patients to select the disconcerting issues and symptoms can be used as a basis for referral, supportive
care and treatment decision making. We need to provide more tailored and personalized information that is
specific to individual circumstances, preferences and concerns and focuses more on the impact of treatment
and access to help and support. Follow up of these patients should be concentrated on both medical and
emotional aspects.
Practice implications: A shift in the way caregivers provide their information contributes to a more profound
involvement of patients in treatment decisions.
Keywords: Shared decision making, Head and neck oncology, Patient involvement
Background
The relevance of patient involvement in treatment
decisions is becoming a more important issue [1, 2].
“The best interest of the patient is the single most
important factor in making treatment decision”
seems to be a straightforward principal underlying
this discussion.
In our opinion it remains unclear what this principal
means for treatment team and the individual patient in
everyday practice.
In this article we want to describe how the principal of
integrating the patient’s perspective can be given
tangible form by giving the missing team member a
voice, reflecting on what type of counselling can improve
patients’ treatment decisions.
Main topic
Giving the missing team member a voice
Involving patients with head and neck cancer in
decisions throughout the treatment pathway can be
particularly problematic.
Firstly, as a group, these patients have tended to be
seen as socially disadvantaged and vulnerable, with poor
health behaviors, including heavy drinking and smoking.
Arguably, this has encouraged a paternalistic attitude
amongst health care professionals, that patients with
head and neck cancer are likely to be passive and even
non-compliant in their behaviors. Additionally, public
awareness of head and neck cancer is poor [3]. Even
studies of medical and dental students reveal a low level
of awareness [4, 5]. And stories of celebrities with head
and neck cancer seem to have less impact on the public
than stories of celebrities with other better-known
cancers [6]. In all, patients with head and neck cancer
tend not to be seen as a vocal, proactive or influential
group. Research has shown that they have high psycho-
logical morbidity [7], high rates of suicide [8] and are
likely to delay seeking treatment [9].
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Secondly, as individuals, people with head and neck
cancer often have to deal with particularly severe and
difficult physical and psychosocial problems [10].
Numerous qualitative studies have shown that patients
with head and neck cancer experience a loss of their
sense of ‘self ’ [11–13]. The contribution of physical and
functional changes to this sense of loss is significant,
including weight loss, changes in appearance or speech,
and difficulties with social activities such as eating and
drinking and kissing, but many patients also describe
losing their sense of who they are as a person. The
experience of cancer can be lonely and uncertain, and
the impact of HNC may be particularly distressing,
because social interaction is so often impaired. Patients
describe their energies being so taken up with getting
through the day, or coping with treatment and its
effects, that they place less emphasis on wider needs and
concerns. In addition, many put on a brave face, com-
pare themselves to others who they perceive as worse
off, or fail to legitimize their symptoms because in com-
parison to the cancer, they seem trivial [11].
Creating an environment in which symptoms are legit-
imized, individuals’ concerns are assessed and peoples’
selves are recognized, is not an easy task within a busy
head and neck cancer clinic. In order to provide the
complex multidisciplinary care that most patients with
head and neck cancer require, a large number of differ-
ent health professionals are likely to be involved, and
this may make it difficult for patients’ own voices to
emerge amongst the many perspectives being shared.
Additionally, the context of the clinic consultation is not
always conducive to an open exchange between the clin-
ician and the patient. An interview- and observational
study of clinic consultations, including those in an ear,
nose and throat clinic, showed that both patients and
health professionals often fail to disclose information
which is highly relevant to decision making [14]. Infor-
mation related to the patient’s problem e.g. symptoms,
beliefs and concerns, and/or information about treat-
ment options e.g. how treatments actually work, uncer-
tainties about effectiveness, was often voiced by patients
and professionals before and after consultations, but not
exchanged during the consultation. There were a num-
ber of reasons for this non-disclosure. These included
the environment of the consultation e.g. too many
people within the room; the attitudes or beliefs of health
care professionals; the wish to portray a particular image
or achieve a particular outcome e.g. by not revealing a
symptom the patient might be given a longer time
period between follow-up appointments; and a belief
that certain information was not worth mentioning or
was felt to be inappropriate to the discussion [14].
Numerous studies also show that clinicians are poor at
recognizing emotional distress and tend to underestimate
symptoms, particularly if they are not directly observable
[15, 16]. Shared decision making is unlikely to occur when
there is no two-way exchange of relevant information.
We therefore need to find better ways of eliciting
patients’ views, experiences, priorities and concerns.
Attitudes to potential treatment outcomes vary between
individuals and it is vital that we do not make assump-
tions about the preferences and priorities of different
people facing the same diagnosis and treatment. If we
are to ensure that patients’ voices and experiences are
more effectively integrated into the treatment pathway,
we need to make routine use of patient reported
outcomes, such as the Patient Concerns Inventory [17]
which asks patients to select the issues and symptoms
that are causing them concern, and can therefore be
used as a basis for referral, supportive care and treat-
ment decision making [18, 19]. Additionally, we need to
re-consider the type of information we offer, providing
more tailored and personalized information that is
specific to individual circumstances, preferences and
concerns and focuses more on the impact of treatment
and access to help and support [20].
Finally, the way we currently follow up patients with
head and neck cancer should be reviewed. Models of
follow-up care vary widely across the world and no
randomized trials exist to guide current practice [21].
Surveillance and monitoring of recurrence clearly
remains extremely important, but supportive care and
rehabilitation is just as crucial if people are to live with
and beyond cancer. In the UK, the National Cancer
Survivorship Initiative was launched in 2010 and has
identified five key shifts that are required in the approach
to care for people living with cancer [22] (see Table 1).
Implementing these shifts will require us to listen
much more carefully to the voices and experiences of
the patients in our care. It will also require us as health
care professionals to work more effectively together
Table 1 Five Key Shifts in the approach to care for people
living with and beyond cancer
• A cultural shift in the approach to care and support for people affected
by cancer to a greater focus on recovery, health and well-being after
cancer treatment
• A shift towards assessment, information & personalised care planning
• A shift towards support for self-management, from a clinically led approach
to follow-up care to supported self-management, based on individual
needs and preferences and with the appropriate clinical assessment,
support and treatment
• A shift from a single model of clinical follow up to tailored support that
enables early recognition of and preparation for the consequences of
treatment as well as early recognition of signs and symptoms of
further disease
• A shift from an emphasis on measuring clinical activity to a new emphasis
on measuring experience and outcomes for cancer survivors through
routine use of patient reported outcome measures in after care services
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across disciplines and across care settings, so that we
can start to make patient involvement in decisions about
treatment and care more of a reality (see Fig. 1).
“The more the group is willing to accept the different
voices emerging from the multidisciplinary clinic, the
more it will be able to listen to the patient’s voice” [23].
Improving treatment decisions in communication with
the patient
Ideally, a decision to undergo a certain type of treatment
should reflect the patients’ preference with full knowledge
of the impact and outcome of all alternatives. In reality,
you can only choose and undergo one alternative at a
time, after which you are no longer the same person as
before this treatment. The individual patient therefore is
limited to decide on the basis of prognostic information
on the group level, provided by health care professionals.
A factor of vital importance in this respect is the way
professionals provide the information (see Fig. 2). It has
been shown in the field of clinical genetics that coun-
selors may be non-directive in the sense of abstaining
from steering advice, but that nevertheless they exert
procedural directivity in the sense of stimulating the
patient to make further use of the health care system –
instead of abandoning it [24]. Often, patients receive no
information on alternative treatments, among these the
option of abstaining from (further) treatment altogether.
Professionals may even lack the knowledge about the
‘natural’ course of the illness.
The same mechanism may be at work in head and
neck oncology and may partly explain why so many
patients choose for invasive treatments, in spite of all
the hardships and bad outcomes.
Patients’ dependency on the way the information is
provided increases with chance information, such as
survival rates after surgery or risk information on side
effects. Patients they have their own chance interpreta-
tions, which may range from unrealistic optimism [25, 26]
to risk-individualization, i.e. the belief that one will be the
very one person with the bad outcome.
The framing of chance information is another factor of
influence. A positive frame (‘This treatment gives you a
chance of survival of 40% ‘) leads to a more risk taking
decision than a negative one (‘… the chance that you’ll
die will be 60%’ [27, 28]. Information in terms of
Fig. 1 Improving patient involvement in treatment decisions. Graphical representation of obstacles encountered in implementing the patients’
voice into the decision making process, and suggested steps to improve patient involvement in treatment decisions
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chances (‘…your survival rate is 20%’) is judged differ-
ently from information in terms of proportions (‘… your
survival rate is 1 in 5’), but the direction of this differ-
ence depends on individual cognitive strategies [29]. The
use of verbal risk information (‘You have a high risk
on…’) generally leads to an overestimation by the patient
of the numerical risk involved [30].
Within the context of these communication aspects,
patients tend to respond in an active way. Treatment
may be seen as a last straw, as a form of reassurance
even, because it offers support, regular contact with
the health care system and a plan of action. In con-
trast, the alternative of abstaining from treatment
may induce uncertainty because one feels left to ones
fate. The negative sides of invasive treatment are dis-
covered when it is already too late. Once treatment
has been started, it may be very difficult to decide to
stop it. In the fields of clinical genetics and neonat-
ology it has been observed that for (parents of )
patients as well as for professionals there is a bias to
continue an already started treatment instead of
terminating it, even in the light of the medical futility
of this treatment [24, 31, 32]. Terminating treatment
would feel the same as giving up all hope, and hope
is the driving force in life [33].
Of all HNO patients every second person will be
in dire need for palliative care within five years [34],
without a clear prognostic indicator being available
for the individual patient. It could be argued
therefore that curative and palliative pathways should
be integrated from diagnosis on, providing good pal-
liation when needed, without sacrifice any chances
for cure.
The integration of palliative care in treatment planning
would mean an enhancement of the choices patients
have in the decision making process. Since the cancer
illness curve is characterized by a sharp decline towards
the end, early integration of palliative aspects in an inte-
grated care plan could prevent many harmful interven-
tions from the curative options towards the inevitable
Fig. 2 Consequences of wording. Schematic overview illustrating consequences of ways professionals use to provide information to patients
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end, whereas, in the earlier phase, no concessions should
be made to curative chances.
It may be concluded that, in communicating treatment
decisions with patients, health care professionals should
be aware of the above mentioned factors. They should
be realistic about side effects of treatment and treatment
outcome, and provide chance information in different
frames. Also, they should be open to the option of
abstaining from treatment or terminating an already
started treatment and help patients to handle this new,
undefined situation.
Patient’s perspective
In order to involve patients’ preference in treatment
decisions, health care professionals not only should
be aware of how they provide information - as out-
lined above -, they also may need actively exploring
patients’ motives regarding (the result of ) treatment.
For both patient and health care professional it may
be hard to estimate the goals and motives of ‘the
opposite party’, making it harder to achieve clarity of
information. The following case illustrates the conse-
quences of an implicit misunderstanding.
Case
Mister O, diabetic since his twenties, was referred with a
tumour in his nose. The tumour had to be removed
surgically with subsequent radiotherapy. He cooperated
in an interview with a clinical psychologist (CLH) after
therapy to discuss the issue of: “Has it been worth it?”.
The interview took place a few months after resection
of his nose, the frontal two third of the maxilla and the
major part of his upper lip. It appeared that mister O
could live very well without his nose: “My face is not who
I am”. But what hampered him most was his discovery of
the maxilla missing after the operation: “Nobody had told
me a thing about that, it’s a shame!”. His denture was diffi-
cult to retain by his upper lip that was now a small band
of tissue without practical function.
Mister O showed himself determined about the sug-
gestion to reconstruct his maxilla and upper lip in one
time: “Over my dead body”. He considered a lengthy op-
eration like that too much of a risk in his situation: “I
don’t care so much for that upper lip”. He only consid-
ered a reconstruction of the lip if that would mean an
enhanced support of the prosthesis.
In order to better fixate the prosthesis installation of
zygomatic implants was suggested, which he also
refused: he expected a higher than average failure risk of
the implants, due to the radiation therapy.
One year later mister O died from a complication of the
same operation he had refused decisively during the inter-
view: an extensive reconstructive surgery, aiming at
restoring both the bony structure of the maxilla as well as
the upper lip, by means of a free vascularised fibula flap.
Another year later his widow was interviewed about
the background of the operation. She was eager to ex-
plain the motives of her husband: “Due to his diabetes
he suffered from erectile dysfunction. I didn’t mind, but
he did. After the nose resection he could no longer use
his upper lip either: he couldn’t kiss me anymore and
that he found awful: ‘If I even can’t do that anymore…’.
And that’s why he decided for the operation: so he could
kiss me again”.
Had the treatment team been aware of mister O’s
motive to agreeing with the operation, his expectations
could have been nuanced. Restoration of the upper lip
would have been mainly aesthetic and functional in the
sense that it would lend more support to the prosthesis
and a better lip closure. But the specific sensory in- and
output desired would have been rather questionable, to
say the least.
Conclusion
The concept of patient involvement in treatment decisions
is widely acknowledged. Less attention is paid to how to
realize this. In Head & Neck Oncology treatment some
factors impede shared decision making. Many disciplines
are involved, making the patient’s voice only one amongst
many. During clinic consultations both health care profes-
sionals and patient seem to fail to disclose information that
is highly relevant to decision making. This is all the more
important as recent literature suggests an association
between depression, post operative functional performance
status and even survival in HNO patients [35, 36]. The
etiology and strength of this relationship is not yet clear. It
would be relevant to know if the usual unilateral nature of
the decision making process enhances the level of depres-
sion in HNO patients, augmenting a perceived lack of
influence and control.
A paradigm shift seems necessary for the transition
from traditional decision making to shared decision
making. A change should take place in what is consid-
ered to be appropriate care for patients living with and
beyond cancer, such as a broadening of the focus on
merely the disease to recovery and well-being after
cancer treatment, a shift to patient’s needs and prefer-
ences for self-management being decisive for follow up
care and creating follow up support that enables patients
to early recognize consequences of treatment and signs
of further disease.
To realize the shift to shared decision making, the
oncology treatment team needs to listen much more
carefully to the voices and experiences of the patients in
care, the team should be aware of the influence it exerts
the way information is provided, and the individual
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members need to work more effectively together across
disciplines and across care settings.
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